APA

Jones H. M., Butt R. P., Webster R. W., Gurrell I., Dzygiel P., Flanagan N., Fraier D., Hay T., Iavarone L. E., Luckwell J., Pearce H., Phipps A., Segelbacher J., Speed B. & Beaumont K. (20170921). Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels. : Clinical pharmacokinetics.

Chicago

Jones Hannah M, Butt Richard P, Webster Rob W, Gurrell Ian, Dzygiel Pawel, Flanagan Neil, Fraier Daniela, Hay Tanya, Iavarone Laura Else, Luckwell Jacquelynn, Pearce Hannah, Phipps Alex, Segelbacher Jill, Speed Bill and Beaumont Kevin. 20170921. Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels. : Clinical pharmacokinetics.

Harvard

Jones H. M., Butt R. P., Webster R. W., Gurrell I., Dzygiel P., Flanagan N., Fraier D., Hay T., Iavarone L. E., Luckwell J., Pearce H., Phipps A., Segelbacher J., Speed B. and Beaumont K. (20170921). Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels. : Clinical pharmacokinetics.

MLA

Jones Hannah M, Butt Richard P, Webster Rob W, Gurrell Ian, Dzygiel Pawel, Flanagan Neil, Fraier Daniela, Hay Tanya, Iavarone Laura Else, Luckwell Jacquelynn, Pearce Hannah, Phipps Alex, Segelbacher Jill, Speed Bill and Beaumont Kevin. Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels. : Clinical pharmacokinetics. 20170921.